BioFuture 2023
October 4, 2023
Hybrid
The BioFuture Selection Committee is looking for public and private companies developing new therapies as well as companies engaged in facilitating the discovery of new therapies. This includes biotech, digital medicine, AI, machine learning, big data, and other companies solving problems in healthcare delivery.
Attend October 4-6 in New York City. Your registration includes full access to panels, workshops and fireside chats featuring key opinion leaders speaking on the most relevant topics and trends. Discover and connect with the most innovative biotech and digital medicine companies in company presentations. Meet and build relationships with investors and potential partners during networking receptions and one-to-one meetings.
In-Person, New York City | October 4-6, 2023
Virtual | October 10-12, 2023
Apply Now to Present
Recent News
- Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
- Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
- Growing collaboration with New York Kidney & Hypertension Medicine
- CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
